BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25381063)

  • 1. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).
    Schmeel LC; Schmeel FC; Coch C; Schmidt-Wolf IG
    J Cancer Res Clin Oncol; 2015 May; 141(5):839-49. PubMed ID: 25381063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy.
    Zhang Y; Schmidt-Wolf IGH
    J Cell Physiol; 2020 Dec; 235(12):9291-9303. PubMed ID: 32484595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).
    Hontscha C; Borck Y; Zhou H; Messmer D; Schmidt-Wolf IG
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):305-10. PubMed ID: 20407789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.
    Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D
    Expert Opin Biol Ther; 2012 Jun; 12(6):673-84. PubMed ID: 22500889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the dual-functional capability of CIK cells be used to improve antitumor effects?
    Wang X; Yu W; Li H; Yu J; Zhang X; Ren X; Cao S
    Cell Immunol; 2014 Jan; 287(1):18-22. PubMed ID: 24355711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors.
    Chu H; Du F; Jiang L; Wang Z; Gong Z; Lian P; Li P; Chen J
    Technol Cancer Res Treat; 2017 Oct; 16(5):577-585. PubMed ID: 27436839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.
    Zhao H; Fan Y; Li H; Yu J; Liu L; Cao S; Ren B; Yan F; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):303-9. PubMed ID: 23506427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma.
    Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R; Guo T
    Cancer Biother Radiopharm; 2010 Aug; 25(4):465-70. PubMed ID: 20701541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.
    Meng Y; Yu Z; Wu Y; Du T; Chen S; Meng F; Su N; Ma Y; Li X; Sun S; Zhang G
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28301281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies.
    Schmeel FC; Schmeel LC; Gast SM; Schmidt-Wolf IG
    Int J Mol Sci; 2014 Aug; 15(8):14632-48. PubMed ID: 25196601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma.
    Liu H; Li J; Wang F; Gao Y; Luo Y; Wang P; Li C; Zhu Z
    Tumour Biol; 2015 Apr; 36(4):2299-307. PubMed ID: 25417201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers.
    Sangiolo D; Martinuzzi E; Todorovic M; Vitaggio K; Vallario A; Jordaney N; Carnevale-Schianca F; Capaldi A; Geuna M; Casorzo L; Nash RA; Aglietta M; Cignetti A
    Int Immunol; 2008 Jul; 20(7):841-8. PubMed ID: 18469328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of relapsed or refractory non-Hodgkin's lymphoma by antigen specific dendritic cells-activated lymphocytes].
    Sun Y; Chen J; Cai P; Hu YH; Zhong GC; Feng HZ; Min M; Li S; Zhang C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):219-23. PubMed ID: 20137151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.
    Dai C; Lin F; Geng R; Ge X; Tang W; Chang J; Wu Z; Liu X; Lin Y; Zhang Z; Li J
    Oncotarget; 2016 Mar; 7(9):10332-44. PubMed ID: 26871284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observation on adoptive immunotherapy with autologous cytokine-induced killer cells for advanced malignant tumor].
    Chen FX; Liu JQ; Zhang NZ; Gong XJ; Zhang GL; Xu YM; Zhou ZH; Wang T; Huang J
    Ai Zheng; 2002 Jul; 21(7):797-801. PubMed ID: 12479111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I-II non-small cell lung cancer after curative surgery.
    Huang J; Zhao X; Zhang Z; Yang S; Chen X; Shen C; Wang L; Qi Y; Zhang Y
    Cytotherapy; 2023 Feb; 25(2):202-209. PubMed ID: 36379882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.